Interaction Guide · Research summary

Can I take Hypericum Perforatum with Triamcinolone?

Review Hypericum Perforatum with Triamcinolone: absorption and effectiveness, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Check with your prescriber before starting or stopping St John’s wort while taking oral triamcinolone. The exact tablet label warns that it can accelerate triamcinolone metabolism and reduce its effect.

What this answer covers

Hypericum perforatum-containing preparations with oral plain triamcinolone; product composition and systemic exposure matter.

Supplement or preparation
Hypericum perforatum
Medication ingredient
triamcinolone

Confirm which triamcinolone you use

This advice concerns plain triamcinolone tablets taken by mouth. Creams, nasal products and injections often contain a different triamcinolone form and have different exposure. Ask your pharmacist to check the full ingredient and route before applying this advice.

Why treatment may become less effective

The tablet label names St John’s wort among products that can speed triamcinolone metabolism. This is a concern about drug breakdown, not evidence that the herb simply binds the tablet in the gut.

Starting and stopping both deserve review

Tell the prescriber if you already use St John’s wort or plan to change it. The label notes that steroid dosing may need adjustment with enzyme-inducing products; that decision belongs to the treating clinician.

Follow your disease-control plan

Report return or worsening of the condition being treated. Do not compensate with extra triamcinolone or assume a few hours between doses solves the problem. Continue the prescribed steroid and taper instructions.

Evidence and practical considerations

Absorption & effectiveness

The oral triamcinolone label specifically identifies Hypericum perforatum as an inducer that can reduce triamcinolone effectiveness.

Exact scope
Hypericum perforatum-containing preparations with oral plain triamcinolone; product composition and systemic exposure matter. with Plain triamcinolone tablets taken orally, exact RxCUI 10759; other forms and routes require separate product assessment.
Medication form and route
oral
Timing or duration
Dose and duration matter; bone guidance principally concerns prolonged systemic treatment.

What remains uncertain

  • Label-supported exact named interaction; no quantitative exact-pair clinical trial identified, no universal extract strength or spacing interval.

Factors that may matter: exact formulation and route; dose and duration; other medicines; supplement preparation; individual nutritional or electrolyte status.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: official product label

swissmedicinfo-pro.ch · Source check Sep 10, 2026

Population: Patients prescribed oral plain triamcinolone.

Risks depend on dose and duration. Lists osteoporosis, muscle weakness, protein catabolism, sodium/fluid retention and potassium loss. Advises protein- and vitamin-rich diet. Specifically names Hypericum perforatum as an inducer that can reduce triamcinolone effect. CYP3A4 inhibitors can reduce clearance. Monitor potassium with potassium-losing medicines and replace if needed.

How this applies: Exact RxCUI 10759 IN identity supported by ingredient name and RxNav record. German professional information translated for scoped oral-product conclusions.

Plain triamcinolone has little mineralocorticoid activity. This is not an acetonide, diacetate or hexacetonide label; topical, inhaled and injected products cannot be assigned the same exposure or precautions automatically. No universal supplement spacing or dose is established.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Exact current claim adjudicated against captured originals with explicit oral-formulation boundary; no clinical review asserted.
Research summary published

Article revision: 7e6b2129574139fb

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.